title: Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer.
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Stacy
authors.initials: S
authors.lastname: Moulder
authors.forename: John
authors.initials: J
authors.lastname: Moroney
authors.forename: Thorunn
authors.initials: T
authors.lastname: Helgason
authors.forename: Jennifer
authors.initials: J
authors.lastname: Wheler
authors.forename: Daniel
authors.initials: D
authors.lastname: Booser
authors.forename: Constance
authors.initials: C
authors.lastname: Albarracin
authors.forename: Phuong K
authors.initials: PK
authors.lastname: Morrow
authors.forename: Kimberly
authors.initials: K
authors.lastname: Koenig
authors.forename: Razelle
authors.initials: R
authors.lastname: Kurzrock
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008679:Metaplasia / Q000473:pathology; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D011960:Receptors, Estrogen / Q000096:biosynthesis; D011980:Receptors, Progesterone / Q000096:biosynthesis; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D033581:Stem Cell Transplantation / Q000639:trends; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D004317:Doxorubicin; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D020123:Sirolimus; C401859:temsirolimus; C508053:ERBB2 protein, human